AusPAR: Padcev

Australian Public Assessment Report

AusPAR

AusPAR: Padcev [PDF, 2.33 MB]

AusPAR: Padcev [Word, 7.08 MB]

AusPAR Attachment 1: Product Information for Padcev [PDF, 677.01 KB]

AusPAR Attachment 1: Product Information for Padcev [Word, 445.19 KB]

Device/Product Name

Padcev

Active ingredients

Enfortumab vedotin

AusPAR Date

27 February 2023

Published

7 March 2023

Submission Number

PM-2021-00635-1-4

Submission Type

New biological entity

Decision

Approved